Mostrando 6 resultados de: 6
Filtros aplicados
Publisher
Frontiers in Pharmacology(1)
Healthcare Papers(1)
Journal of Pharmaceutical Health Services Research(1)
PLoS ONE(1)
Revista Panamericana de Salud Publica/Pan American Journal of Public Health(1)
Área temáticas
Farmacología y terapéutica(4)
Problemas sociales y servicios a grupos(4)
Producción(3)
Medicina y salud(2)
Salud y seguridad personal(2)
Origen
scopus(6)
EMA and FDA decisions based on flawed evidence to approve new cancer drugs negatively affect Latin American patients
OtherAbstract:Palabras claves:Autores:Cañás M., Carlos E. Durán, Chistiaens T.Fuentes:scopusMyocarditis and pericarditis associated with SARS-CoV-2 vaccines: A population-based descriptive cohort and a nested self-controlled risk interval study using electronic health care data from four European countries
ArticleAbstract: Background: Estimates of the association between COVID-19 vaccines and myo-/pericarditis risk vary wPalabras claves:adverse drug reaction, COVID-19 Vaccine, myocarditis , Pericarditis, pharmacovigilanceAutores:Alsina E., Aragón M., Belitser S.V., Bots S.H., Carlos E. Durán, Douglas I.J., García-Poza P., Gini R., Herings R.M.C., Huerta C., Klungel O.H., Martin I., Martín-Pérez M., Messina D., Overbeek J.A., Pallejà-Millán M., Paoletti O., Riera-Arnau J., Schultze A., Sisay M.M., Souverein P., Sturkenboom M.C.J.M., Swart K.M.A., Villalobos F.Fuentes:scopusRegulatory reliance to approve new medicinal products in Latin American and Caribbean countries
ArticleAbstract: Objective. To describe the current status of regulatory reliance in Latin America and the CaribbeanPalabras claves:Caribbean Region, Drug approval, Government Agencies, Latin America, Pan american health organization, Pharmaceutical preparations, United States Food and Drug AdministrationAutores:Andia T., Cañás M., Carlos E. Durán, Christiaens T., Elseviers M., Stichele R.V., Urtasun M.A.Fuentes:scopusPolicies influencing access to new targeted oncologic drugs in Ecuadorian hospitals: an interrupted time series analysis
ArticleAbstract: Objective and methods: An interrupted time series analysis was performed to measure the impact of twPalabras claves:antineoplastic drugs, drug and therapeutic committees, drug policies, ECUADOR, interrupted time series analysis, molecular targeted therapyAutores:Carlos E. Durán, Christiaens T., Elseviers M., Patricia Granja, Rottey S., Vander Stichele R.Fuentes:scopusPotential negative impact of reputed regulators decisions on the approval status of new cancer drugs in Latin American countries: A descriptive analysis
ArticleAbstract: Background Many new cancer drugs are being approved by reputed regulatory authorities without evidenPalabras claves:Autores:Cañás M., Carlos E. Durán, Christiaens T., Elseviers M., Stichele R.V., Urtasun M.A.Fuentes:scopusStrong regional integration mechanisms should be at the core of new global health coordination models
ReviewAbstract: The implications for individual countries acting on their self-interest are radically different depePalabras claves:Autores:Andia T., Carlos E. Durán, Vance C.Fuentes:scopus